Topotecan: a review of its efficacy in small cell lung cancer.
about
A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.Advances in systemic therapy of small cell cancer of the lung.Factors affecting pharmacokinetic variability of oral topotecan: a population analysisMultipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer.Anti-HSV activity of camptothecin analogues.Asymmetric α-hydroxylation of a lactone with vinylogous pyridone by using a guanidine-urea bifunctional organocatalyst: catalytic enantioselective synthesis of a key intermediate for (20S)-camptothecin analogues.
P2860
Topotecan: a review of its efficacy in small cell lung cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Topotecan: a review of its efficacy in small cell lung cancer.
@ast
Topotecan: a review of its efficacy in small cell lung cancer.
@en
Topotecan: a review of its efficacy in small cell lung cancer.
@nl
type
label
Topotecan: a review of its efficacy in small cell lung cancer.
@ast
Topotecan: a review of its efficacy in small cell lung cancer.
@en
Topotecan: a review of its efficacy in small cell lung cancer.
@nl
prefLabel
Topotecan: a review of its efficacy in small cell lung cancer.
@ast
Topotecan: a review of its efficacy in small cell lung cancer.
@en
Topotecan: a review of its efficacy in small cell lung cancer.
@nl
P1433
P1476
Topotecan: a review of its efficacy in small cell lung cancer.
@en
P2093
P304
P356
10.2165/00003495-199958030-00020
P577
1999-09-01T00:00:00Z
P6179
1008372655